Clever AI (CEO Song Hyung-seok) was invited to the ‘Korea-UK Bio & Technology’ forum held last month on the Department of Business, Energy and Industrial Strategy in London and made a presentation on the theme of ‘Implementation of Artificial Intelligence (AI) within the Healthcare Field’ 6 the day said

The Korea-UK Bio & Technology Forum is an event jointly hosted by the Ministry of Science and ICT of Korea, the Korean Embassy within the UK, the British Embassy in Korea, and the British Medical Research Council (MRC) to share the most recent technology trends between the 2 countries in the sphere of digital bio and share the longer term. It’s a forum held to hunt cooperation strategies for brand spanking new technologies.

At this forum, which celebrated its second 12 months, discussions were held on the theme of ‘Modern Approach of Bio & AI Platform for Well-being/Smart Living and Disease Management’, and techniques for sustainable partnership between the 2 countries were discussed.

Particularly, world-renowned scholars equivalent to Professor Chas Buntra of Oxford University, a world drug development expert, Professor David Kleneman of Cambridge University, who was nominated for the 2021 Nobel Prize in Chemistry, Professor Kay Jo of King’s College, an authority on dementia, Professor Noh Young of Gachon Gil University, and Dr. Lee Dae-hee of Korea Research Institute of Bioscience and Biotechnology. About 10 expert researchers from the British Dementia Research Institute (UK DRI), Korea Institute of Science and Technology (KIST), and Institute for Basic Science (IBS) attended the forum that day.

In front of them, CEO Song introduced the AI ​​call assistant platform ‘AiME’, which is about to enter the worldwide market, and provided dementia diagnosis assistance and care services to people around the globe through ‘AiME’, a sophisticated Amy service. Presented business vision and strategy to offer

As well as, he explained the achievements of self-developed AI solutions equivalent to SSAM-Verse, an AI customer center that gives services to hospitals and corporations, and emphasized the expansion potential, innovation, and excellence of domestic AI corporations.

Song Hyeong-seok, CEO of YISAI, said, “It’s an honor to introduce YISAI’s vision at a meaningful event where scholars and experts from various fields gather to debate for the expansion of the bio industry in each countries.” “Our ultimate goal is to offer AI care services.”

As well as, “With the recommendation of Professor Kay Jo King’s College, who’s currently a world-renowned dementia authority, we joined hands with ‘UK DRI’, the UK’s largest dementia research institute, and Switch, a British information security and security company, and Gachon University Gil Hospital in Korea and the Royal Hospital in England participate together. We’re preparing for a world joint technology research project within the UK and establishing a step-by-step business roadmap.”

Reporter Juyoung Lee juyoung09@aitimes.com